NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
New York, New York-- (Newsfile Corp. - January 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
Zacks.com on MSN5d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
View TransMedics Group, Inc. (TMDX) current and estimated P/E ratio data provided by Seeking Alpha.
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback